~~<i id='7F073A8386'><strike id='7F073A8386'><tt id='7F073A8386'><pre id='7F073A8386'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：hotspot 2025-10-01 17:35:04 - browse：25356

JUUL store sign -- health coverage from STAT — Stephanie Keith/Getty Images

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

It’s not clear how much the company ultimately spent on the partnerships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Group behind ProMed defends move to subscription

hotspot

focus

explore

hotspot

leisure time

AdobeScientistsaretaughtearlyinourtrainingthatcriticismisafundamentalpartofthejob.Whatwearenotusuall

WSS

Ebola: Gilead Sciences antiviral shows promise as new treatment

Medicare slashes safety net hospital payments by nearly $1 billion

When waiting feels immoral: Empathy in the emergency department

Group behind ProMed defends move to subscription

Why depression after traumatic brain injury is distinct

The cancer stories no one wants to hear

focus

hotspot

hotspot

New air purifier tech could be key to improving indoor air quality

FDA advisers back CAR

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Peter Hotez and the public health issue of online harassment

The cancer stories no one wants to hear

Cancer drug shortages should be causing more outrage

Amid AI frenzy, a top HHS official's quest to create safeguards

Moonlake's readout produced a cash windfall. Risks remain

EPA limits use of carcinogenic gas for sterilizing medical devices

focus

Heart disease in astronauts blamed on cosmic radiation

Heart disease in astronauts blamed on cosmic radiation

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA approves Sage Therapeutics’ rapid

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

focus

explore

hotspot

leisure time